BVF Inc’s Crescent Biopharma CBIO Stock Holding History

BVF Inc’s Portfolio CBIO Stock Details CBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$50.5M	Hold	2,748,763	–	–	1.61%	21
2025 Q4	$32.6M	Buy	2,748,763 +1,360,900	+98%	+$17.3M	1.1%	27
2025 Q3	$16.5M	Hold	1,387,863	–	–	0.67%	32
2025 Q2	$22.4M	Buy	1,387,863 +1,292,420	+1,354%	+$27.3M	0.8%	23
2025 Q1	$2M	Hold	95,443	–	–	0.08%	46
2024 Q4	$2.38M	Hold	95,443	–	–	0.08%	48
2024 Q3	$1.61M	Hold	95,443	–	–	0.05%	49
2024 Q2	$2.69M	Hold	95,443	–	–	0.08%	50
2024 Q1	$28.6M	Hold	95,443	–	–	0.79%	31
2023 Q4	$22.5M	Hold	95,443	–	–	0.56%	36
2023 Q3	$14.3M	Hold	95,443	–	–	0.39%	38
2023 Q2	$16.6M	Hold	95,443	–	–	0.46%	38
2023 Q1	$12M	Hold	95,443	–	–	0.44%	46
2022 Q4	$28.9M	Hold	95,443	–	–	1.22%	29
2022 Q3	$5.27M	Hold	95,443	–	–	0.22%	60
2022 Q2	$5.71M	Hold	95,443	–	–	0.28%	56
2022 Q1	$10.9M	Hold	95,443	–	–	0.44%	55
2021 Q4	$13.7M	Hold	95,443	–	–	0.5%	48
2021 Q3	$20.9M	Hold	95,443	–	–	0.85%	36
2021 Q2	$22.1M	Hold	95,443	–	–	0.83%	31
2021 Q1	$28.7M	Hold	95,443	–	–	1.08%	25
2020 Q4	$35.9M	Buy	95,443 +23,000	+32%	+$8.06M	1.41%	26
2020 Q3	$22.2M	Hold	72,443	–	–	1.21%	28
2020 Q2	$27.2M	Sell	72,443 -1,175	-2%	-$333K	1.68%	22
2020 Q1	$16.8M	Hold	73,618	–	–	1.56%	20
2019 Q4	$38.9M	Hold	73,618	–	–	2.95%	11
2019 Q3	$31.7M	Buy	+73,618	New	+$47.3M	3.33%	10
2018 Q1	–	Sell	-4,975	Closed	-$8.35M	–	45
2017 Q4	$8.35M	Sell	4,975 -27,324	-85%	-$36.1M	1.01%	26
2017 Q3	$45.2M	Buy	32,299 +2,597	+9%	+$3.05M	5.74%	6
2017 Q2	$33.1M	Buy	29,702 +1,439	+5%	+$1.19M	5.15%	6
2017 Q1	$15.3M	Hold	28,263	–	–	2.61%	13
2016 Q4	$17.2M	Buy	28,263 +4,000	+16%	+$2.5M	3.46%	10
2016 Q3	$17.3M	Sell	24,263 -211	-0.9%	-$161K	3.27%	11
2016 Q2	$17.8M	Buy	+24,474	New	+$16.9M	3.79%	9

Other funds holding CBIO

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Balyasny Asset Management

Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return